Skip to main content

Table 1 Clinical characteristics of the study participants

From: Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study

Parameters

IGT group (n = 108)

Control group (n = 84)

P value

Sex (M/F)

65/43

44/40

0.279

Age (years)

57.31 ± 7.21

56.83 ± 7.55

0.651

BMI (kg/m2)

26.43 ± 4.83

24.26 ± 3.44

0.001

SBP (mmHg)

128.11 ± 6.86

126.46 ± 6.89

0.101

DBP (mmHg)

75.62 ± 6.50

74.14 ± 7.38

0.142

TC (mmol/L)

5.15 ± 1.06

4.92 ± 0.91

0.109

HDL-C (mmol/L)

1.34 ± 0.27

1.58 ± 0.37

<0.001

LDL-C (mmol/L)

3.10 ± 0.74

2.85 ± 0.75

0.024

TG (mmol/L)

2.37 (1.99, 2.79)

1.09 (0.71, 1.48)

<0.001

ApoA-I (g/L)

1.37 ± 0.36

1.57 ± 0.39

<0.001

ApoB (g/L)

0.97 ± 0.22

0.90 ± 0.23

0.030

ApoA-I/HDL-C

0.99 (0.91, 1.10)

0.99 (0.85, 1.11)

0.821

FBG (mmol/L)

6.30 (5.60, 6.98)

5.58 (5.24, 5.82)

<0.001

2hPG (mmol/L)

9.30 (8.63, 9.80)

6.50 (6.08, 6.73)

<0.001

HbA1c (%)

6.30 (6.00, 6.40)

5.90 (5.60, 6.10)

<0.001

FINS (mIU/L)

15.70 (10.80, 18.30)

8.17 (5.39, 11.97)

<0.001

HOMA-IR

4.21 ± 1.56

2.15 ± 0.99

<0.001

  1. IGT group, patientswith impaired glucose tolerance; Control group, control subjects; BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglycerides, apoA-I apolipoprotein A-I, apoB apolipoprotein B, FBG fasting blood glucose, 2hPG 2-h postchallenge glucose, HbA1c glycated hemoglobin, FINS fasting insulin, HOMA-IR homeostasis model assessment of insulin resistance